Litigation Details for SENJU PHARMACEUTICAL CO., LTD. v. INNOPHARMA LICENSING, INC. (D.N.J. 2014)
✉ Email this page to a colleague
SENJU PHARMACEUTICAL CO., LTD. v. INNOPHARMA LICENSING, INC. (D.N.J. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-11-03 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-10-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | None | Referred To | Karen M. Williams |
| Patents | 8,129,431; 8,669,290; 8,754,131; 8,871,813; 8,927,606 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SENJU PHARMACEUTICAL CO., LTD. v. INNOPHARMA LICENSING, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SENJU PHARMACEUTICAL CO., LTD. v. INNOPHARMA LICENSING, INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-08-10 | 48 | the patents-in-suit, U.S. Patent Nos. 8,129,431 (“the ’431 patent”), 8,669,290 (“the ’290 patent”), …8,754,131 (“the ’131 patent”), 8,871,813 (“the ’813 patent”), and 8,927,606 (“the ’606 patent”). (Ex.1 1; Ex…claim 1 of the ’290 patent, claim 1 of the ’131 patent, claim 1 of the ’813 patent, and claim 1 of the… Notice Letter and Local Patent Rule contentions regarding the ’431 patent, stating that claims 1 and… and Claims of the Patents-in-Suit The ’431, ’290, ’131, and ’813 patents disclose and claim | External link to document | |
| 2015-08-10 | 52 | Claim Constructions for U.S. Patent Nos. 8,754,131; 8,669,290; 8,129,431; 8,927,606; and 8,871,813-- (…2014 13 October 2016 1:14-cv-06893 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
